A detailed history of North Crest Asset Manangement, LLC transactions in Geron Corp stock. As of the latest transaction made, North Crest Asset Manangement, LLC holds 31,575 shares of GERN stock, worth $125,984. This represents 0.0% of its overall portfolio holdings.

Number of Shares
31,575
Previous 31,500 0.24%
Holding current value
$125,984
Previous $133,000 7.52%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$4.17 - $4.99 $312 - $374
75 Added 0.24%
31,575 $143,000
Q2 2023

Jul 21, 2023

BUY
$1.97 - $3.69 $62,055 - $116,235
31,500 New
31,500 $101,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.51B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track North Crest Asset Manangement, LLC Portfolio

Follow North Crest Asset Manangement, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of North Crest Asset Manangement, LLC, based on Form 13F filings with the SEC.

News

Stay updated on North Crest Asset Manangement, LLC with notifications on news.